One of the mechanisms by which the innate immune system senses the invasion of pathogenic microorganisms is through Toll-like receptors (TLRs), which recognize specific molecular patterns that are present in microbial components. Stimulation of different TLRs induces distinct patterns of gene expression, which not only leads to the activation of innate immunity, but also instructs the development of antigen-specific acquired immunity (1, 2) .
TLR signaling predominantly induces interferon (IFN) regulatory factors (IRFs), and nuclear factor-κB (NF-κB) and AP1 activation. This elicits the production of type I interferon and inflammatory cytokines (3, 4) . TLR signaling also facilitates the selection of microbial antigens for presentation by dendritic cells (5) . Parasitic protozoans can also trigger TLRs enhancing resistance to them by triggering pro-inflammatory responses (6) . Ten members of the TLR family have been identified in human, and 13 in mice (4) . Signaling by TLRs involves five adaptor proteins known as MyD88, MyD88-adapter like (MAL), TIR-domaincontaining adaptor protein inducing IFNβ (TRIF), TRIF-related adaptor molecule (TRAM), and sterile α-and armadillomotif-containing protein (SARM). MAL recruits MyD88 to TLR2 and TLR4, and TRAM recruits TRIF to TLR4 to allow IRF3 activation.
SARM negatively regulates TRIF.
MyD88 is the key signaling adaptor for all TLRs with the exception of TLR3 and a subset of TLR4 signals, which utilize Trif (7).
Autophagy is a cellular response to starvation as well as a quality control system that can remove damaged organelles and longlived proteins from cytoplasm. Autophagy plays a role in programmed cell death; the promotion and prevention of cancer; neurodegeneration; and cellular defense to remove invading pathogens (8) . Recently, it has been recognized that autophagy is involved in both innate and adaptive immunity against intracellular protozoa, bacteria and viruses (9) (10) (11) . Autophagy has been implicated in major histocompatibility complex (MHC) class II antigen presentation.
During autophagy cytoplasmic materials are sequestered into double membrane coated autophagosomes, which fuse with endosomes and lysosomes to form autolysosomes where the contents are degraded by lysosomal enzymes. Autophagy is a constitutively active pathway in all MHC class II positive cells, where the autophagosomes continuously fuse with the multivesicular MHC class II-loading compartment.
This provides a potential mechanism for class II positive cells to continuously present cytosolic contents to CD4 + T cells (12). Beclin 1, the mammalian homologue of yeast Atg6, is a key component of a Class III phosphatidylinositol 3-kinase (PI3K) complex that initiates autophagosome formation helping to localize other autophagy proteins to the pre-autophagosomal membrane (13) . Bcl2 is an anti-apoptotic protein, which binds Beclin 1, and is known to inhibit autophagy (14) .
In this study, we use macrophages to test the potential of a panel of TLR ligands to trigger autophagy. We find that MyD88 and Trif to interact with Beclin 1 and Bcl2 and that TLR signaling alters the balance, which is likely critical in triggering autophagy.
Experimental Procedures
Cell culture and GPF-LC3 stably transduced cell line-RAW 264.7 cells were obtain from ATCC (American Type Culture Collection, Rockville, MD); and were maintained in DMEM 10% FBS. The LC3 cDNA was a gift from Dr. Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan). RAW 264.7 cells were transfected with GFP-LC3 construct, using FuGene HD Transfection Reagent (Roche Applied Science, Basel, Switzerland). The transfection protocol from the manufacture was followed. 24 h after transfection G418 400 μg/ml (Mediatech, Hemdon, VA) was added to select positive cells for 3 weeks; after which the positive cells were enriched by cell sorting and maintained. Plasmids -Full length Flag-MyD88, its Cterminal and N-terminal truncation constructs were kindly provided by Dr. A. Ding (Cornell University).
The dominant-negative Trif construct was a gift from Dr. S. Akira (Osaka University, Osaka, Japan The cell lysates were centrifuged, and equivalent amounts of protein were loaded onto 4-20% or 10% Tris/glycine/SDS-polyacrylamide gels (Invitrogen).
After electrophoresis, the proteins were transferred to nitrocellulose membranes.
The specific antibodies as indicated were used for immunoblots. For coimmunoprecipitation assays, a modified lysis buffer was used. Instead of 1 % Triton X-100 and 0.2% SDS, 0.5 % Triton and 0.5% CHAPS were used. The lysates were incubated with antibodies for 2 h at 4 0 C, and then Protein G PLUS-Agarose was added and incubated for 1 h at 4 0 C. The immunoprecipitated beads were washed with 0.5ml of the same buffer 8 times. The immunoprecipitates were subjected to SDS-PAGE gel electrophoresis and MyD88, Trif, and Beclin 1 detected by immunoblot analysis as described above.
RESULTS

TLRs induce autophagy in murine macrophages.
To detect autophagosome formation, green fluorescent protein fused to LC3 (GFP-LC3) was used as a surrogate marker. LC3 is a mammalian homologue of yeast Atg8, which is a specific constituent of the yeast autophagosomal membrane. LC3 exists in two forms, an 18 kilodalton (kDa) cytosolic form (LC3-I) and a 16 kDa processed form (LC3-II), which localizes on the autophagosome membrane, where it functions in autophagosome enlargement (16) .
To determine whether TLRs induce autophagy in RAW 264.7 macrophages, we used a stably transfected cell line that expresses GFP-LC3. When autophagosomes form, GFP-LC3 is processed and recruited to the autophaosome membrane, where it can be imaged by confocal microscopy (Fig. 1A) . The percentages of GFP-LC3 positive cells that have GFP-LC3 dots can be counted and are indicative of autophagosome formation. We treated the RAW 264.7/GFP-LC3 cells with different TLR ligands for 7 h and found that signaling through TLR1, TLR3, TLR4, TLR5, TLR6 and TLR7 induced significant increases in autophagosome formation. Ligands for TLR4, TLR7, TLR1, TLR3, TLR5 and TLR6 induced autophagy in 55%, 42%, 37%, 32%, 24% and 21% of the cells, respectively. Interestingly, signaling through TLR1 or TLR3 induced similar responses, despite their use of different adaptor proteins, MydD88 for TLR1 and Trif for TLR3.
Ligands for TLR9 triggered autophagosome formation in 9% of the cells, only slightly above the basal level of 4% (Fig.  1B) . To provide further evidence of TLR induced autophagosome formation, we examined endogenous LC3-I and LC3-II levels by immunoblotting using either TLR4 or TLR3 ligands to treat the cells. While the LC3-I band predominated in the untreated macrophages we could detect some LC3-II even in the absence of TLR ligand exposure. However, treatment with TLR3 or TLR4 ligands decreased the LC3-I band and increased the LC3-II band consistent with our previous assay (Fig. 1C) . We also confirmed the TLR-induced autophagy at the ultrastructural level by electron microscopy. Both TLR3 and TLR4 signaling led to the appearance of autophagic vacuoles, doublemembrane vacuolar structures containing cytoplasmic contents.
Non-treated cells showed a few small autophagic vacuoles, some of which contained mitochondrial membranes. After TLR4 activation, we visualized large autophagic vacuoles in the cytoplasm of the RAW 264.7 cells, in which organelles did not exist. Activation of TLR3 with Poly(I:C) induced some large autophagic vacuoles as well as some smaller vacuoles (Fig. 1D ). Together these data indicate that TLR signaling leads to autophagosome formation.
MyD88, Trif, and Beclin 1 are involved in triggering autophagy in RAW 264.7 cells. TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4). Beclin 1 interacts with the class III phosphoinositide-3-kinase (Vps34) to localize other autophagy proteins to the preautophagosmal membrane (17) .
Bcl-2 binds Beclin 1 and functions as a brake to autophagy and autophagic cell death perhaps by affecting the interaction between Beclin 1 and Vsp34 (14) . As an initial test of MyD88 or Trif involvement in the mediation of autophagosome formation, we expressed either MyD88 or Trif with GFP-LC3 in RAW 264.7 cells.
We found that MyD88 or Trif expression led to GFP-LC3 dots in 60-70% of the GFP-LC3 positive cells, nearly similar to that achieved by the overexpression of Beclin 1. We also expressed the TIR-domain containing adapters SARM and TRAM along with GFP-LC3 in RAW 264.7. As a expected, SARM, which is a negative regulator of TLR signaling (18) did not induce autophagy; however, expression of TRAM, which acts as a bridging adaptor for Trif-induced signaling(7), led to a moderate induction of autophagy ( Fig. 2A) . Together these data suggest that TLR signaling through MyD88 and/or Trif leads to autophagosome formation.
MyD88 has a death domain at its NH 2 -terminal, which links it to downstream effectors in the TLR signaling pathways and a Toll/Interleukin receptor (TIR) domain at its COOH-terminal, which interacts with cytoplasmic portion of various TLRs. An Nterminally truncated MyD88 functions as a dominant negative (19) . The TIR domain of Trif has similar behavior (20) . We used the dominant negative constructs or expressed shRNAs that target MyD88, Trif, or Beclin 1 to verify the roles of MyD88 and Trif in TLR4 and TLR3 induced autophagy. RAW 264.7 cells were transfected with the various constructs and GFP-LC3, treated 24 h later with either LPS or Poly(I:C), and 7 h later autophagosome formation were measured by counting the percentage of GFP-LC3 positive cells that contained GFP-LC3 dots. Expression of the MyD88 or the Trif dominant negative form reduced LPS-induced autophagosome formation by 58% and 33%, respectively, while shRNAs targeting MyD88 or Trif reduced LPS-induced autophagosome formation by 67% and 50%, respectively. Two Beclin 1 shRNAs targeted at distinct sites in the Beclin 1 mRNA reduced autophagosome formation by 55% and 41% (Fig. 2B) . Next, we examined whether Trif and Beclin 1 are required for Poly(I:C) activated TLR3-induced autophagosome formation. Using a similar experimental protocol, the expression of the Trif dominant negative form reduced TLR3 induced autophagosome formation by 55% while the Trif shRNA reduced it 62%. The Beclin 1 shRNAs had similar effects as observed with TLR4 induced autophagosome formation (Fig. 2C) . We also examined endogenous LC3-I and LC3-II levels following TLR3 or TLR4 signaling by immunoblotting cell lysates prepared from RAW 264.7 cells previously transfected with the Trif, MyD88, or Beclin 1 shRNAs. Consistent with the data using the RAW 264.7 cells transfected with GFP-LC3, reducing Trif, MyD88 or Beclin 1 impaired TLR4 or TLR3 induced increases in the LC3-II/ LC3-I ratio (Fig. 2, D and E) . The efficacy of the shRNAs in reducing MyD88, Trif, and Beclin 1 is shown (Fig. 2F) .
Activated TLR4 recruits Beclin 1, MyD88, and Trif. In an attempt to link TLR signaling to autophagy, we examined whether activated TLR4 signaling recruited Beclin 1 into the TLR4 signaling complex. To do so we treated RAW 264.7 cells with an agonistic TLR4 antibody or a control antibody for 15 min, 1, and 4 h prior to cell lysis. In addition we added the same antibodies to non-treated cell lysates, which served as a time zero point. We immunoprecipitated the TLR4 antibody or control antibody and immunoblotted for associated proteins (Fig. 3A) . Beclin 1 coimmunoprecitated with the TLR4 antibody, but not the control.
The TLR4-Beclin 1 interaction increased with time and the Beclin 1 bands shifted upward suggesting a modification of Beclin 1. As expected the TLR4 adaptors, MyD88 and Trif immunoprecipitated with TLR4. With the duration of exposure of the agonistic antibody, we detected more MyD88 and an altered mobility of Trif. The TLR4 antibody signaling also led to the recruitment of the protein kinase Irak4, a known member of the TLR4 signaling complex (4). Immunoblotting the cell lysates for Beclin 1 and IκB-α expression revealed no change in Beclin 1 expression and degradation of IκB-α indicating NF-κB activation. (Fig.  3A) . To determine the relative importance of the MyD88 death and TIR domains in recruiting Beclin-1, we expressed tagged versions of full length, TIR domain truncated, and death domain truncated MyD88 and examined their interaction with endogenous Beclin 1. The death domain of MyD88 pulled down Beclin 1, while the death domain deleted version did not (Fig. 3B) .
Furthermore, expression of the death domain of MyD88 induced autophagy nearly as well as full length MyD88, whereas the death domain deleted version did not (data not shown). We also showed that Trif immunoprecipitates prepared from Trif transfected cells contained endogenous Beclin 1 (Fig. 3C) . These data strongly suggest that ligand activated TLR4 assembles a signaling complexes that containing MyD88, Trif, Irak4, and Beclin 1.
MyD88 and Trif modulate the interaction between Bcl2 and Beclin 1. The anti-apoptotic protein Bcl-2 inhibits starvationinduced autophagy via targeting the BH3-like domain in Beclin 1 (14, 21) (Fig. 4A ). Bcl-2 immunoprecipitates from lysates prepared from the same experiment were examined for the presence of MyD88, Trif, of Beclin 1. We found both MyD88 and Trif in the Bcl-2 immunoprecipitates, the levels of which increased slightly following signaling. In addition, a striking decrease in the Bcl2 and Beclin 1 interaction occurred (Fig. 4B) . Furthermore, when we immunoprecipitated MyD88 following exposure of RAW 267.4 cells to LPS we noted a large increase in coimmunoprecipitated Beclin 1 (Fig. 4C) . Recently, induction of autophagy via TLR7 has been shown to depend on MyD88 and Beclin 1 expression (22) . We found that similar to activated TLR4, activated TLR7 also enhanced the association between MyD88 and Beclin 1, and deceased Bcl-2 binding with Beclin 1 (Fig. 4D) . Next, we asked whether MyD88 or Bcl2 over-expression affected the interaction between Bcl2 and Beclin 1, or the association of Beclin 1 with MyD88 and Trif. Empty vector, MyD88, the MyD88 death domain (NT), or the death domain deleted version (CT) were transfected into RAW 264.7 cells. The expression of MyD88 or the MyD88 death domain reduced the coimmunoprecipitation of Beclin 1 with Bcl-2 by 60 and 70 percent, respectively, while the death domain deleted version did not affect it (Fig. 4E) . Overexpression of Bcl2 led to a reduced association between Beclin 1 and Trif as well as MyD88 (Fig. 4F) . Since Beclin 1 has a BH-3 like domain, which is critical for binding with Bcl2, we examined the ability of a BH-3 domain mutant, Beclin 1 L116A, to associate with MyD88 and Trif. As we had observed previously, wild type Beclin 1 readily co-immunoprecipitated Trif, MyD88, and Beclin 1, while Beclin 1 L116A was much less efficient (Fig. 4G) . These results suggested that MyD88 and Trif may actively regulate autophagy by targeting the interaction between Beclin 1 and Bcl2.
Bcl2 inhibits TLR-induced autophagy and MyD88 or Trif compete with Bcl2 to regulate Beclin 1 triggered autophagy.
Given that MyD88 and Trif may regulate the Beclin 1-Bcl2 complex, we determined whether Bcl2 is able to attenuate TLRs induced autophagy in RAW 267.4 cells. The GFP-LC3 autophagy marker assay showed that overexpression of Bcl2 significantly suppressed LPS and Poly(I:C) induced autophagy (Fig. 5A) . Furthermore, the expression of MyD88 or Trif partially reversed the inhibition by Bcl2 of Beclin 1 induced autophagy. Neither the death domain deleted version of MyD88 nor the dominant negative form of Trif had a significant effect (Fig. 5B) . The above results further support the concept that MyD88 and Trif are activators, while Bcl2 is an inhibitor of TLR-induced autophagy and each of these proteins likely targets Beclin 1.
DISCUSSION
The activation of innate immune systems is based on sensing the invasion of pathogenic microorganisms through pattern recognition receptors like Toll-like receptors, which recognize specific molecular signatures that are present in microbial components. Much attention has been focused upon TLRmediated activation of NF-κB, mitogen activated protein kinases, and interferon regulatory factors (4, 23) . Here, we provide a linkage between TLR receptor signaling and the signaling pathway that leads to autophagy. We have focused on the signaling pathway downstream of TLR4, which leads to the induction of autophagy and have shown that the TLR4 adapter proteins MyD88 and Trif either directly or indirectly recruit Beclin 1 into the TLR4 signaling complex. This reduces the interaction between Beclin 1 and Bcl-2 and results in a biochemical modification of Beclin 1. The release of Beclin 1 from Bcl-2 biases the cell towards autophagy. We also have shown that TLR7 induced autophagy uses a similar mechanism.
Autophagy has been shown to play a role in macrophage antimicrobial activity. It is a defense mechanism that inhibits the survival of Mycobacterium tuberculosis in infected macrophages (24) and CD40 triggers autophagy in macrophages to help eliminate Toxoplasma gondii infection (25) . Mice lacking MyD88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)-and TLR4-deficient animals (26, 27) .
Since our investigation demonstrates defective TLRinduced autophagy from multiple Toll receptors, a failure to induce autophagy in MyD88 deficient mice could help explain the defects in host resistance in mice lacking MyD88.
Recently, TLR4 has been reported to be a sensor for autophagy in RAW 264.7 macrophages. However in contrast to our results a Trif dependent, but MyD88 independent, TLR4 signaling pathway was found responsible.
Receptor-interacting protein (RIP1) and P38 mitogen-activated protein kinase were downstream components of the pathway (28 Xu et al. showed that LPS signaling led to the an increase of VPS34 in the particulate fraction, which suggests an enhanced incorporation of the VSP34 complex into membranes. VPS34 is a class III PI3K that functions in autophagy as a catalytic subunit in a complex with Beclin 1 (13) . We found that similar to MyD88, Trif either directly or indirectly associates with Beclin 1. The data with the TLR4 agonistic antibody indicates that Beclin 1 directly associates with the TLR4 signaling complex and by analogy the TLR3 signaling complex. This data also revealed modification(s) of Beclin 1 that slowed its mobility on SDS-PAGE. Since we did not detect a change in the mobility of Beclin 1 in cell lysates, the Beclin 1 modification likely occurs following recruitment to the TLR4 signaling complex. An initial slight shift in the mobility was followed by a more dramatic shift. Prime candidates to cause such changes would be phosphorylation followed by ubiquitination.
L . The pharmacological BH3 mimetic ABT737 competitively inhibits the interaction and antagonizes autophagy, while inhibition of Bcl2 stimulates autophagy. The BH3 domain mutant L116A of Beclin 1 loses binding to Bcl2 and Bcl-X L (21) . In our study the same mutant lost most of its ability to coimmunoprecipitate MyD88 and Trif. Overall our results suggest that a similar mechanism regulates TLR-induced autophagy in macrophages.
We found that Bcl2 overexpression attenuated TLR-dependent autophagy. MyD88 and Trif function as autophagic activators.
TLR signaling enhances the presence of Beclin 1 in the signaling complex while reducing the interaction between Bcl-2 and Beclin 1, thereby promoting autophagy. Another interesting finding is that the death domain of MyD88 is required for the association with Beclin 1, and that overexpression of this domain by itself can induce autophagy. This result suggests a possible crosstalk pathway between autophagy and apoptosis, in which other death domain proteins might also interact with Beclin 1 to regulate autophagy.
In our study we have predominantly relied on two methods for monitoring the induction of autophagosome formation by TLR signaling both which depend upon LC3 cleavage. LC3 is a homologue of Atg8 in yeast which during autophagy is cleaved to become LC3-I and LC3-II. While LC3-I is cytosolic, LC3-II is enriched on the autophagic vacuole. When GFP-LC3 expressing cells undergo autophagy LC3-II appears on newly formed autophagosomes visible as cytoplasmic puncta, which can be quantified by fluorescence microscopy. Alternatively, western blotting of LC3-I and LC3-II can be performed and the ratio between the two monitored. These two methods have been extensively using for detecting autophagosome formation (30) . While electron microscopy can be used to visualize autophagy, it is difficult to quantify and impractical for signaling experiments.
In conclusion, not only TLR4 but also engagement of TLR1, TLR3, TLR5, TRL6 and TLR7 leads to autophagy in macrophages. Activated TLR4 recruited a protein complex contained MyD88, Trif and Beclin 1. MyD88 or Trif likely serves as activators for autophagy in macrophages along with Beclin 1 and triggers a reduction in the interaction between Bcl2 and Beclin 1. Autophagy has emerged as a novel effector for TLRs facilitating innate as well as acquired immunity against a variety of pathogens.
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